View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Erdafitinib 8, urinary Bladder Cancer
Protocol-ID: 2001 V1.0 (Mini), ERDA8, Bladder CancerIndication(s)
- Bladder Cancer (FGFR2/3 Fusion, FGFR3 Mutation); ICD-10 C67.-
Links
- Prescribing information for Erdafitinib (BALVERSA) (FDA) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 18.03.2022